Céline Gheeraert obtained a Master's degree in Cellular and Molecular Engineering from the University of Lille in 2006. She began her professional career at GENFIT, a biotechnology company based in Lille, where she contributed to projects focused on identifying novel pharmacological treatments for diseases associated with metabolic syndrome.

In 2008, she joined the unit under the direction of Dr. Philippe Lefebvre as an engineer, where she developed expertise in cistrome analysis techniques and epigenomic modifications (ChIPseq, CUT&RUN, (h)MeDIPseq). She also set up and managed a gene expression microarray platform (Affymetrix technology) before evolving this technological approach towards the use of “new generation” sequencing (RNAseq/snRNAseq).

For several years, under the supervision of Dr. Jérôme Eeckhoute, she has focused on studying the transcriptional networks that regulate cell identity in liver pathophysiology. Her research particularly investigates the role of transcription factors in maintaining and modulating hepatic identity under both normal and pathological conditions.

Dernières actualités